Anbio Biotechnology (NASDAQ:NNNN – Get Free Report) shares gapped up before the market opened on Tuesday. The stock had previously closed at $3.27, but opened at $3.43. Anbio Biotechnology shares last traded at $3.8530, with a volume of 90,792 shares.
Analysts Set New Price Targets
Separately, Weiss Ratings raised Anbio Biotechnology from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Thursday, October 8th. One analyst has rated the stock with a Hold rating. According to MarketBeat.com, Anbio Biotechnology presently has a consensus rating of “Hold”.
Check Out Our Latest Analysis on Anbio Biotechnology
Anbio Biotechnology Stock Performance
The firm has a 50 day simple moving average of $6.10 and a two-hundred day simple moving average of $15.11.
About Anbio Biotechnology
Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.
See Also
- Five stocks we like better than Anbio Biotechnology
- GM Beat and Added a $20 Billion Buyback—Why Did the Stock Fall?
- Intercepting Growth: Karman Secures $218M Lockheed Martin Deal
- Tech Stocks Took a Hit—These 2 Pharma Stocks Are Near New Highs
- Chip Stocks Have Pulled Back—Here’s How 3 Semiconductor ETFs Stack Up for Investors
Receive News & Ratings for Anbio Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anbio Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
